{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:14:49Z","timestamp":1791360889526,"version":"4.3.1"},"reference-count":129,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Interleukin (IL)-38, a newly discovered IL-1 family cytokine, is expressed in several tissues and secreted by various cells. IL-38 has recently been reported to exert an anti-inflammatory function by binding to several receptors, including interleukin-36 receptor (IL-36R), interleukin-1 receptor accessory protein-like 1 (IL-1RAPL1), and interleukin-1 receptor 1 (IL-1R1) to block binding with other pro-inflammatory cytokines and inhibit subsequent signaling pathways; thereby regulating the differentiation and function of T cells, peripheral blood mononuclear cells, macrophages, and dendritic cells. Inflammatory autoimmune diseases, which are common immune-mediated inflammatory syndromes, are characterized by an imbalance between T helper cells (Ths), especially Th1s and Th17s, and regulatory T cells (Tregs). Recent findings have shown that abnormal expression of IL-38 in inflammatory autoimmune diseases, such as rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, primary Sjogren\u2019s syndrome, psoriasis, inflammatory bowel disease, hidradenitis suppurativa, ankylosing spondylitis, and glaucoma, involves Th1s, Th17s, and Tregs. In this review, the expression, regulation, and biological function of IL-38 are discussed, as are the roles of IL-38 in various inflammatory autoimmune disorders. Current data support that the IL-38\/IL-36R and\/or IL-38\/IL-1RAPL1 axis primarily play an anti-inflammatory role in the development and resolution of inflammatory autoimmune diseases and indicate a possible therapeutic benefit of IL-38 in these diseases.<\/jats:p>","DOI":"10.3390\/biom9080345","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T11:17:47Z","timestamp":1565003867000},"page":"345","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["IL-38: A New Player in Inflammatory Autoimmune Disorders"],"prefix":"10.3390","volume":"9","author":[{"given":"Lihui","family":"Xie","sequence":"first","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohao","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxing","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-4774","authenticated-orcid":false,"given":"Song","family":"Guo Zheng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ohio State University College of Medicine, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-6362","authenticated-orcid":false,"given":"Wenru","family":"Su","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong 510000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12624","article-title":"Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_2","first-page":"15","article-title":"Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases","volume":"245","author":"Pan","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_3","first-page":"43","article-title":"RORgammat+IL-17+ neutrophils play a critical role in hepatic ischemia-reperfusion injury","volume":"51","author":"Tan","year":"2013","journal-title":"J. Mol. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"E3246","DOI":"10.1073\/pnas.1421463112","article-title":"Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1","volume":"112","author":"Gao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","first-page":"E3432","article-title":"Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions","volume":"111","author":"Lan","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26872","DOI":"10.1074\/jbc.M114.586651","article-title":"PIM1 Kinase Phosphorylates the Human Transcription Factor FOXP3 at Serine 422 to Negatively Regulate Its Activity under Inflammation *","volume":"289","author":"Li","year":"2014","journal-title":"J. Boil. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fimmu.2016.00604","article-title":"Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms","volume":"7","author":"Luo","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_8","first-page":"99","article-title":"Bowden. Identification of a Novel Human Cytokine Gene in the Interleukin Gene Cluster on Chromosome 2q12-14","volume":"218","author":"Bensen","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"20597","DOI":"10.1074\/jbc.M010095200","article-title":"Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member","volume":"276","author":"Lin","year":"2001","journal-title":"J. Boil. Chem."},{"key":"ref_10","first-page":"73","article-title":"IL-1 family nomenclature","volume":"119","author":"Dinarello","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_11","first-page":"167","article-title":"New Insights in the Immunobiology of IL-1 Family Members","volume":"4","author":"Netea","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1006\/geno.2002.6751","article-title":"A Sequence-Based Map of the Nine Genes of the Human Interleukin-1 Cluster","volume":"79","author":"Nicklin","year":"2002","journal-title":"Genom."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","article-title":"Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family","volume":"275","author":"Kumar","year":"2000","journal-title":"J. Boil. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jmcb\/mjw006","article-title":"Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses","volume":"8","author":"Mora","year":"2016","journal-title":"J. Mol. Cell Boil."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1134\/S0026893316030134","article-title":"Production of recombinant human interleukin-38 and its inhibitory effect on the expression of proinflammatory cytokines in THP-1 cells","volume":"50","author":"Yuan","year":"2016","journal-title":"Mol. Boil."},{"key":"ref_16","first-page":"1","article-title":"IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist","volume":"1093","author":"Stoeckman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1172\/JCI97965","article-title":"Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation","volume":"128","author":"Zou","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fimmu.2019.00178","article-title":"1,25-Dihydroxyvitamin D3 Ameliorates Collagen-Induced Arthritis via Suppression of Th17 Cells Through miR-124 Mediated Inhibition of IL-6 Signaling","volume":"10","author":"Zhou","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.3390\/ijms150814269","article-title":"Expert Panel Workshop Consensus Statement on the Role of the Environment in the Development of Autoimmune Disease","volume":"15","author":"Parks","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent Insights in the Epidemiology of Autoimmune Diseases: Improved Prevalence Estimates and Understanding of Clustering of Diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J. Autoimmun."},{"key":"ref_21","first-page":"94","article-title":"Regulatory T cells vs. Th17: Differentiation of Th17 versus Treg, are the mutually exclusive?","volume":"2","author":"Zheng","year":"2013","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bcp.2017.06.136","article-title":"Sodium butyrate regulates Th17\/Treg cell balance to ameliorate uveitis via the Nrf2\/HO-1 pathway","volume":"142","author":"Chen","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1203\/PDR.0b013e31819e76c7","article-title":"The Treg\/Th17 Cell Balance: A New Paradigm for Autoimmunity","volume":"65","author":"Eisenstein","year":"2009","journal-title":"Pediatr. Res."},{"key":"ref_24","first-page":"548","article-title":"Antigen-specific transforming growth factor beta-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17\/Treg cell balance from Th17 predominance to Treg cell predominance","volume":"642","author":"Kong","year":"2012","journal-title":"Arthr. Rheum."},{"key":"ref_25","first-page":"112","article-title":"Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6","volume":"1807","author":"Zheng","year":"2008","journal-title":"J. Immunol."},{"key":"ref_26","first-page":"46","article-title":"FoxP3+ CD4+ T cells in systemic autoimmune diseases: The delicate balance between true regulatory T cells and effector Th-17 cells","volume":"506","author":"Abdulahad","year":"2011","journal-title":"Rheumatology"},{"key":"ref_27","first-page":"251","article-title":"The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients","volume":"291","author":"Ma","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaci.2008.12.017","article-title":"Differentiation and functional analysis of human TH17 cells","volume":"123","author":"Burgler","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_29","first-page":"59","article-title":"Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease","volume":"1841","author":"Boutet","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/art.39328","article-title":"Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated with Disease Activity in Systemic Lupus Erythematosus","volume":"67","author":"Rudloff","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/03009740903447028","article-title":"The interleukin-1 family gene polymorphisms in Korean patients with rheumatoid arthritis","volume":"39","author":"Jung","year":"2010","journal-title":"Scand. J. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/annrheumdis-2011-200439","article-title":"Association between the IL-1 family gene cluster and spondyloarthritis","volume":"71","author":"Monnet","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/art.21928","article-title":"Association between the interleukin-1 family gene cluster and psoriatic arthritis","volume":"54","author":"Rahman","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_34","first-page":"106","article-title":"Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese","volume":"651","author":"Chou","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1744-313X.2009.00889.x","article-title":"Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population","volume":"37","author":"Guo","year":"2010","journal-title":"Int. J. Immunogenet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.110.948570","article-title":"Meta-analysis of genome-wide association studies in >80,000 subjects identifies multiple loci for C-reactive protein levels","volume":"123","author":"Dehghan","year":"2011","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dorajoo, R., Li, R., Ikram, M.K., Liu, J., Froguel, P., Lee, J., and Young, T.L. (2013). Are C-Reactive Protein Associated Genetic Variants Associated with Serum Levels and Retinal Markers of Microvascular Pathology in Asian Populations from Singapore?. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067650"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/807976","article-title":"Role of IL-38 and Its Related Cytokines in Inflammation","volume":"2015","author":"Yuan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/bioinformatics\/11.6.681","article-title":"SOPMA: Significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments","volume":"11","author":"Geourjon","year":"1995","journal-title":"Bioinformation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/annrheumdis-2016-210630","article-title":"IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro","volume":"76","author":"Boutet","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2006-04-014852","article-title":"Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate","volume":"108","author":"Weigert","year":"2006","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18R\u03b1 and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Lo","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1136\/annrheumdis-2017-211793","article-title":"Response to: Does IL-38 act on macrophages and\/or dendritic cells in arthritis?","volume":"77","author":"Boutet","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Palomo, J., Troccaz, S., Talabot-Ayer, D., Rodriguez, E., and Palmer, G. (2018). The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194667"},{"key":"ref_45","first-page":"1003","article-title":"The interleukin-1 family: Back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunology"},{"key":"ref_46","first-page":"94","article-title":"The interleukin-1 receptor family","volume":"253","author":"Boraschi","year":"2013","journal-title":"Semin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2011.07.410","article-title":"CS16-5. IL-36R Ligands are Potent Regulators of Dendritic and T Cells","volume":"56","author":"Vigne","year":"2011","journal-title":"Cytokine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201142035","article-title":"Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9","volume":"42","author":"Mutamba","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"42594","DOI":"10.1074\/jbc.M111.267922","article-title":"Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36\u03b1, IL-36\u03b2 and IL-36\u03b3) or antagonist (IL-36Ra) activity","volume":"286","author":"Towne","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MIB.0000000000000654","article-title":"Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease","volume":"22","author":"Hidaka","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1681\/ASN.2016080840","article-title":"IL-36 Signaling Facilitates Activation of the NLRP3 Inflammasome and IL-23\/IL-17 Axis in Renal Inflammation and Fibrosis","volume":"28","author":"Chi","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fimmu.2012.00322","article-title":"TIR8\/SIGIRR is an Interleukin-1 Receptor\/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity","volume":"3","author":"Riva","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1080\/14397595.2018.1436118","article-title":"Analysis of serum IL-38 in juvenile-onset systemic lupus erythematosus","volume":"28","author":"Takeuchi","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jbspin.2011.06.010","article-title":"The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: A meta-analysis","volume":"79","author":"Lea","year":"2012","journal-title":"Jt. Bone Spine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000471798","article-title":"New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions","volume":"233","author":"Li","year":"2017","journal-title":"Dermatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cei.12644","article-title":"Interleukin-36\u03b1 axis is modulated in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"181","author":"Ciccia","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Chu, M., Chu, I.M., Yung, E.C., Lam, C.W., Leung, T.F., Wong, G.W., and Wong, C.K. (2016). Aberrant Expression of Novel Cytokine IL-38 and Regulatory T Lymphocytes in Childhood Asthma. Molecules, 21.","DOI":"10.3390\/molecules21070933"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/s41598-017-03079-z","article-title":"The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3748\/wjg.v22.i18.4529","article-title":"Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B","volume":"22","author":"Wang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Takada, K., Okamoto, T., Tominaga, M., Teraishi, K., Akamine, T., Takamori, S., Katsura, M., Toyokawa, G., Shoji, F., and Okamoto, M. (2017). Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181598"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/490120","article-title":"Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment","volume":"2015","author":"Zhong","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Derer, A., Groetsch, B., Harre, U., Bohm, C., Towne, J., Schett, G., Frey, S., and Hueber, A.J. (2014). Blockade of IL-36 Receptor Signaling Does Not Prevent from TNF-Induced Arthritis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101954"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar4192","article-title":"The severity of experimental arthritis is independent of IL-36 receptor signaling","volume":"15","author":"Lamacchia","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/annrheumdis-2017-211780","article-title":"Dendritic cells should not be overlooked when studying the effect of IL-38 administration in arthritis","volume":"77","author":"Jiang","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/12623","article-title":"A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation","volume":"23","author":"Jun","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"29946","DOI":"10.1074\/jbc.M004077200","article-title":"Identification and Characterization of Two Members of a Novel Class of the Interleukin-1 Receptor (IL-1R) Family: Delineation of a new class of IL-1R-related proteins based on signaling","volume":"275","author":"Born","year":"2000","journal-title":"J. Boil. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/cib.3.3.11414","article-title":"Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions","volume":"3","author":"Pavlowsky","year":"2010","journal-title":"Commun. Integr. Boil."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3389\/fimmu.2018.00702","article-title":"Long Non-Coding RNA GAPLINC Promotes Tumor-Like Biologic Behaviors of Fibroblast-Like Synoviocytes as MicroRNA Sponging in Rheumatoid Arthritis Patients","volume":"9","author":"Mo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5312\/wjo.v5.i4.516","article-title":"Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications","volume":"5","author":"Magyari","year":"2014","journal-title":"World J. Orthop."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jbspin.2008.04.005","article-title":"Shifting the imbalance from Th1\/Th2 to Th17\/treg: The changing rheumatoid arthritis paradigm","volume":"75","author":"Boissier","year":"2008","journal-title":"Jt. Bone Spine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jbspin.2010.08.017","article-title":"Cell and cytokine imbalances in rheumatoid synovitis","volume":"78","author":"Boissier","year":"2011","journal-title":"Jt. Bone Spine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_74","first-page":"277","article-title":"Rheumatoid arthritis: Pathophysiology and implications for therapy","volume":"3221","author":"Harris","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_75","first-page":"647","article-title":"Mechanism of IL-38 inhibits LPS\/TLR4 induced inflammation in patients with rheumatoid arthritis","volume":"1","author":"Zhe","year":"2017","journal-title":"Chin. J. Immunol."},{"key":"ref_76","first-page":"386","article-title":"IL-38: A new factor in rheumatoid arthritis","volume":"4","author":"Takenaka","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_77","first-page":"31","article-title":"Detection of the novel IL-1 family cytokines by QAH-IL1F-1 assay in rheumatoid arthritis","volume":"62","author":"Wang","year":"2016","journal-title":"Cell. Mol. Boil."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2018.09.028","article-title":"Plasma interleukin-38 in patients with rheumatoid arthritis","volume":"65","author":"Xu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar1946","article-title":"The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes","volume":"8","author":"Magne","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"ref_80","first-page":"569","article-title":"The novel cytokine interleukin-36\u03b1 is expressed in psoriatic and rheumatoid arthritis synovium","volume":"721","author":"Frey","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.4049\/jimmunol.1000598","article-title":"Cutting Edge: All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells in an Inflammatory Milieu","volume":"185","author":"Zhou","year":"2010","journal-title":"J. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.191.2.313","article-title":"Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist-Deficient Mice","volume":"191","author":"Horai","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/art.24126","article-title":"Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses","volume":"58","author":"Fujimoto","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/art.23957","article-title":"Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice","volume":"58","author":"Koenders","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/41.9.972","article-title":"Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage","volume":"41","author":"Abramson","year":"2002","journal-title":"Rheumatology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/art.27235","article-title":"Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell\u2013specific interleukin-1 receptor antagonist","volume":"62","author":"Lamacchia","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","article-title":"From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/art.10173","article-title":"Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein","volume":"46","author":"Bush","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.1780360915","article-title":"The effect of an interleukin-1 receptor antagonist protein on type ii collagen\u2013induced arthritis and antigen-induced arthritis in mice","volume":"36","author":"Wooley","year":"1993","journal-title":"Arthritis Rheum."},{"key":"ref_90","first-page":"86","article-title":"IL-36 in psoriasis","volume":"124","author":"Towne","year":"2012","journal-title":"Curr. Opin. Pharm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-5699(95)80132-4","article-title":"Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens?","volume":"16","author":"Valdimarsson","year":"1995","journal-title":"Immunol. Today"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.1003162","article-title":"IL-1F5, F6, F8, and F9: A novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression","volume":"186","author":"Johnston","year":"2011","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","article-title":"Are psoriasis and psoriatic arthritis the same disease? The IL-23\/IL-17 axis data","volume":"16","author":"Sakkas","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional Blood and Target Tissue CD4+CD25 high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.celrep.2019.03.082","article-title":"IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from gammadelta T Cells","volume":"27","author":"Han","year":"2019","journal-title":"Cell. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","article-title":"IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment","volume":"9","author":"Mercurio","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jdermsci.2016.02.003","article-title":"Up-regulation of receptor antagonist interleukin-1 family members in psoriasis and their regulation by pro-inflammatory cytokines","volume":"82","author":"Kim","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2015.08.002","article-title":"Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin","volume":"80","author":"Keermann","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1084\/jem.20070157","article-title":"Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation","volume":"204","author":"Blumberg","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.4049\/jimmunol.1000313","article-title":"IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis","volume":"185","author":"Blumberg","year":"2010","journal-title":"J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36\u2013Receptor Antagonist Deficiency and Generalized Pustular Psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"New Engl. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.0022-202X.2004.22305.x","article-title":"Psoriasis-Like Cutaneous Inflammation in Mice Lacking Interleukin-1 Receptor Antagonist","volume":"122","author":"Shepherd","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4049\/jimmunol.159.7.3364","article-title":"Phenotypic and functional characterization of mice that lack the type I receptor for IL-1","volume":"159","author":"Glaccum","year":"1997","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4049\/jimmunol.159.5.2452","article-title":"Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice","volume":"159","author":"Labow","year":"1997","journal-title":"J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","article-title":"IL-36 promotes myeloid cell infiltration, activation and inflammatory activity in skin","volume":"192","author":"Foster","year":"2014","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.4049\/jimmunol.1302574","article-title":"Alarmin Function of Cathelicidin Antimicrobial Peptide LL37 through IL-36\u03b3 Induction in Human Epidermal Keratinocytes","volume":"193","author":"Li","year":"2014","journal-title":"J. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Rabeony, H., Petit-Paris, I., Garnier, J., Barrault, C., Pedretti, N., Guilloteau, K., Jegou, J.-F., Guillet, G., Huguier, V., and Lecron, J.-C. (2014). Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1\u03b1, TNF\u03b1 and Oncostatin M. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101937"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.01.004","article-title":"Diagnostic criteria for systemic lupus erythematosus: A critical review","volume":"48","author":"Yu","year":"2014","journal-title":"J. Autoimmun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/823085","article-title":"Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New","volume":"2012","author":"Alunno","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"19588","DOI":"10.3390\/molecules201019588","article-title":"Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus","volume":"20","author":"Chu","year":"2015","journal-title":"Molecules"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.smim.2013.11.003","article-title":"Biology of IL-36 cytokines and their role in disease","volume":"25","author":"Gresnigt","year":"2013","journal-title":"Semin. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.imbio.2016.10.012","article-title":"In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)\/lpr mice","volume":"222","author":"Chu","year":"2017","journal-title":"Immunobiology"},{"key":"ref_113","first-page":"1","article-title":"Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease","volume":"2017","author":"Guan","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/mi.2015.134","article-title":"IL-36\u03b1 expression is elevated in ulcerative colitis and promotes colonic inflammation","volume":"9","author":"Russell","year":"2016","journal-title":"Mucosal Immunol."},{"key":"ref_115","first-page":"1","article-title":"Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease","volume":"2018","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/01.MIB.0000480273.37247.26","article-title":"P-146 IL-36 Receptor Is Required for Resolution of Intestinal Damage","volume":"22","author":"Harusato","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4049\/jimmunol.1501312","article-title":"Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage","volume":"196","author":"Harusato","year":"2016","journal-title":"J. Immunol."},{"key":"ref_118","first-page":"34","article-title":"Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sj\u00f6gren\u2019s syndrome: Findings in humans and mice","volume":"587","author":"Nguyen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.16019","article-title":"Interleukin-36 in hidradenitis suppurativa: Evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop","volume":"178","author":"Hessam","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2013.06.013","article-title":"Genetics of ankylosing spondylitis","volume":"57","author":"Robinson","year":"2014","journal-title":"Mol. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2016.04.031","article-title":"Autoimmune aspects in glaucoma","volume":"787","author":"Bell","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.intimp.2019.03.016","article-title":"Novel inflammatory cytokines (IL-36, 37, 38) in the aqueous humor from patients with chronic primary angle closure glaucoma","volume":"71","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: Mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2010.22","article-title":"The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease","volume":"7","author":"Leung","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ni0907-903","article-title":"T H-17 differentiation: Of mice and men","volume":"89","author":"Laurence","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.3260","article-title":"How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy","volume":"19","author":"Schett","year":"2013","journal-title":"Nat. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"180132","DOI":"10.1098\/rsob.180132","article-title":"Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression","volume":"8","author":"Wang","year":"2018","journal-title":"Open Biol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/8\/345\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:08:50Z","timestamp":1760188130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/8\/345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":129,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["biom9080345"],"URL":"https:\/\/doi.org\/10.3390\/biom9080345","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]}}}